Skip to Main Content

Paper Details

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
JAMA Oncol
125
2020
APC, ATRX, CDKN2A, Cancer, Cancer-Susceptibility Genes, Li-Fraumeni syndrome, MEN1, MSH2, Osteosarcoma, POT1, Participants, Patients, TP53, VHL, autosomal-dominant gene, cancer, cancer-susceptibility gene variant, cancer-susceptibility genes, candidate genes, children, familial cancer syndromes, genetic variants, germline, malignant bone tumor, osteosarcoma, patient, patients
Author NameAffiliation
Lisa MirabelloNational Cancer Institute, National Institutes of Health
Lisa MirabelloNational Cancer Institute, National Institutes of Health
Roelof KosterNational Cancer Institute, National Institutes of Health
Roelof KosterNational Cancer Institute, National Institutes of Health
Eric KarlinsFrederick National Laboratory for Cancer Research
Michael DeanNational Cancer Institute, National Institutes of Health
Michael DeanFrederick National Laboratory for Cancer Research
Meredith YeagerFrederick National Laboratory for Cancer Research
Meredith YeagerFrederick National Laboratory for Cancer Research
Logan G SpectorUniversity of Minnesota
Logan G SpectorUniversity of Minnesota
Leslie L RobisonSt Jude Children's Research Hospital
Leslie L RobisonSt Jude Children's Research Hospital
Gregory T ArmstrongSt Jude Children's Research Hospital
Gregory T ArmstrongSt Jude Children's Research Hospital
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Nathan PankratzUniversity of Minnesota
Nathan PankratzUniversity of Minnesota
Julie M Gastier-FosterNationwide Children's Hospital, The Ohio State University
Julie M Gastier-FosterNationwide Children's Hospital, The Ohio State University
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Richard GorlickUniversity of Texas MD Anderson Cancer Center
Silvia Regina Caminada de ToledoInstituto de Oncologia Pediatrica, Grupo de Apoio ao Adolescente e a Crianca com Cancer/Universidade Federal de Sao Paulo
Silvia Regina Caminada de ToledoInstituto de Oncologia Pediatrica, Grupo de Apoio ao Adolescente e a Crianca com Cancer/Universidade Federal de Sao Paulo
Antonio Sergio PetrilliInstituto de Oncologia Pediatrica, Grupo de Apoio ao Adolescente e a Crianca com Cancer/Universidade Federal de Sao Paulo
Antonio Sergio PetrilliInstituto de Oncologia Pediatrica, Grupo de Apoio ao Adolescente e a Crianca com Cancer/Universidade Federal de Sao Paulo
Ana Pati??o-Garc??aUniversity Clinic of Navarra and Center for Applied Medical Research, Navarra Institute for Health Research
Ana Pati??o-Garc??aCenter for Applied Medical Research, University of Navarra, Instituto de Investigacion Sanitaria de Navarra
Ana Pati??o-Garc??aUniversity Clinic of Navarra and Center for Applied Medical Research, Navarra Institute for Health Research
Ana Pati??o-Garc??aCenter for Applied Medical Research, University of Navarra, Instituto de Investigacion Sanitaria de Navarra
Fernando LecandaUniversity Clinic of Navarra and Center for Applied Medical Research, Navarra Institute for Health Research
Fernando LecandaCenter for Applied Medical Research, University of Navarra, Instituto de Investigacion Sanitaria de Navarra
Fernando LecandaUniversity Clinic of Navarra and Center for Applied Medical Research, Navarra Institute for Health Research
Fernando LecandaCenter for Applied Medical Research, University of Navarra, Instituto de Investigacion Sanitaria de Navarra
Massimo SerraIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Massimo SerraIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Claudia Maria HattingerIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Claudia Maria HattingerIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Piero PicciIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Piero PicciIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Katia ScotlandiIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Katia ScotlandiIstituto di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli
Adrienne M FlanaganUCL Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Adrienne M FlanaganUCL Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Fernanda AmaryRoyal National Orthopaedic Hospital NHS Trust
  • 1 - 50

Datasets

Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink
Exome Aggregation Consortium61,486 unrelated exomesLink